What are the side effects of Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial be used during pregnancy?

( AHT ) For the active ingredient ursodeoxycholic acid You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial?

Eckert & Ziegler Radiopharma GmbH (BE)

What ATC class does Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial belong to?

Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial: ATC V10X Other Therapeutic Radiopharmaceuticals. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Yttriga 0.1 GBq/ml - 300 GBq/ml radiopharmac. precursor vial

Radiopharmaceutical precursor

INN: Yttrium (Y-90)

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧

Form

Radiopharmaceutical precursor

Dosage

—

Route

Route of administration not applicable

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.